A citation-based method for searching scientific literature

G Tallini, S L Asa. Adv Anat Pathol 2001
Times Cited: 150







List of co-cited articles
1168 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


RET/PTC rearrangement in thyroid tumors.
Yuri E Nikiforov. Endocr Pathol 2002
307
46


BRAF mutation in thyroid cancer.
M Xing. Endocr Relat Cancer 2005
946
35

Correlation between genetic alterations and microscopic features, clinical manifestations, and prognostic characteristics of thyroid papillary carcinomas.
Adebowale J Adeniran, Zhaowen Zhu, Manoj Gandhi, David L Steward, James P Fidler, Thomas J Giordano, Paul W Biddinger, Yuri E Nikiforov. Am J Surg Pathol 2006
342
34

PAX8-PPARgamma1 fusion oncogene in human thyroid carcinoma [corrected].
T G Kroll, P Sarraf, L Pecciarini, C J Chen, E Mueller, B M Spiegelman, J A Fletcher. Science 2000
630
34

BRAF mutations in thyroid tumors are restricted to papillary carcinomas and anaplastic or poorly differentiated carcinomas arising from papillary carcinomas.
Marina N Nikiforova, Edna T Kimura, Manoj Gandhi, Paul W Biddinger, Jeffrey A Knauf, Fulvio Basolo, Zhaowen Zhu, Riccardo Giannini, Giuliana Salvatore, Alfredo Fusco,[...]. J Clin Endocrinol Metab 2003
767
32

Pathogenetic mechanisms in thyroid follicular-cell neoplasia.
Tetsuo Kondo, Shereen Ezzat, Sylvia L Asa. Nat Rev Cancer 2006
650
32


Prevalence of RET/PTC rearrangements in thyroid papillary carcinomas: effects of the detection methods and genetic heterogeneity.
Zhaowen Zhu, Raffaele Ciampi, Marina N Nikiforova, Manoj Gandhi, Yuri E Nikiforov. J Clin Endocrinol Metab 2006
149
30

The ret/PTC mutations are common in sporadic papillary thyroid carcinoma of children and young adults.
C L Fenton, Y Lukes, D Nicholson, C A Dinauer, G L Francis, R M Tuttle. J Clin Endocrinol Metab 2000
170
30

RAS point mutations and PAX8-PPAR gamma rearrangement in thyroid tumors: evidence for distinct molecular pathways in thyroid follicular carcinoma.
Marina N Nikiforova, Roy A Lynch, Paul W Biddinger, Erik K Alexander, Gerald W Dorn, Giovanni Tallini, Todd G Kroll, Yuri E Nikiforov. J Clin Endocrinol Metab 2003
484
29

Pattern of radiation-induced RET and NTRK1 rearrangements in 191 post-chernobyl papillary thyroid carcinomas: biological, phenotypic, and clinical implications.
H M Rabes, E P Demidchik, J D Sidorow, E Lengfelder, C Beimfohr, D Hoelzel, S Klugbauer. Clin Cancer Res 2000
252
28

PTC is a novel rearranged form of the ret proto-oncogene and is frequently detected in vivo in human thyroid papillary carcinomas.
M Grieco, M Santoro, M T Berlingieri, R M Melillo, R Donghi, I Bongarzone, M A Pierotti, G Della Porta, A Fusco, G Vecchio. Cell 1990
821
27

RET/PTC oncogene activation defines a subset of papillary thyroid carcinomas lacking evidence of progression to poorly differentiated or undifferentiated tumor phenotypes.
G Tallini, M Santoro, M Helie, F Carlomagno, G Salvatore, G Chiappetta, M L Carcangiu, A Fusco. Clin Cancer Res 1998
234
27

BRAF mutation predicts a poorer clinical prognosis for papillary thyroid cancer.
Mingzhao Xing, William H Westra, Ralph P Tufano, Yoram Cohen, Eli Rosenbaum, Kerry J Rhoden, Kathryn A Carson, Vasily Vasko, Alexandr Larin, Giovanni Tallini,[...]. J Clin Endocrinol Metab 2005
721
25

RET/PTC rearrangements in thyroid nodules: studies in irradiated and not irradiated, malignant and benign thyroid lesions in children and adults.
R Elisei, C Romei, T Vorontsova, B Cosci, V Veremeychik, E Kuchinskaya, F Basolo, E P Demidchik, P Miccoli, A Pinchera,[...]. J Clin Endocrinol Metab 2001
209
25

Molecular characterization of RET/PTC3; a novel rearranged version of the RETproto-oncogene in a human thyroid papillary carcinoma.
M Santoro, N A Dathan, M T Berlingieri, I Bongarzone, C Paulin, M Grieco, M A Pierotti, G Vecchio, A Fusco. Oncogene 1994
305
23

Heterogeneity in the distribution of RET/PTC rearrangements within individual post-Chernobyl papillary thyroid carcinomas.
Kristian Unger, Horst Zitzelsberger, Giuliana Salvatore, Massimo Santoro, Tatjana Bogdanova, Herbert Braselmann, Peter Kastner, Lyudmilla Zurnadzhy, Nikolay Tronko, Peter Hutzler,[...]. J Clin Endocrinol Metab 2004
100
22

Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer.
David S Cooper, Gerard M Doherty, Bryan R Haugen, Richard T Kloos, Stephanie L Lee, Susan J Mandel, Ernest L Mazzaferri, Bryan McIver, Furio Pacini, Martin Schlumberger,[...]. Thyroid 2009
22

The RET/PTC3 oncogene: metastatic solid-type papillary carcinomas in murine thyroids.
D J Powell, J Russell, K Nibu, G Li, E Rhee, M Liao, M Goldstein, W M Keane, M Santoro, A Fusco,[...]. Cancer Res 1998
185
21

Molecular profile and clinical-pathologic features of the follicular variant of papillary thyroid carcinoma. An unusually high prevalence of ras mutations.
Zhaowen Zhu, Manoj Gandhi, Marina N Nikiforova, Andrew H Fischer, Yuri E Nikiforov. Am J Clin Pathol 2003
284
21

Oncogenic AKAP9-BRAF fusion is a novel mechanism of MAPK pathway activation in thyroid cancer.
Raffaele Ciampi, Jeffrey A Knauf, Roswitha Kerler, Manoj Gandhi, Zhaowen Zhu, Marina N Nikiforova, Hartmut M Rabes, James A Fagin, Yuri E Nikiforov. J Clin Invest 2005
311
20


BRAF mutation in papillary thyroid carcinoma.
Yoram Cohen, Mingzhao Xing, Elizabeth Mambo, Zhongmin Guo, Guogun Wu, Barry Trink, Uziel Beller, William H Westra, Paul W Ladenson, David Sidransky. J Natl Cancer Inst 2003
636
20

Targeted expression of BRAFV600E in thyroid cells of transgenic mice results in papillary thyroid cancers that undergo dedifferentiation.
Jeffrey A Knauf, Xiaolan Ma, Eric P Smith, Lei Zhang, Norisato Mitsutake, Xiao-Hui Liao, Samuel Refetoff, Yuri E Nikiforov, James A Fagin. Cancer Res 2005
308
20

Analysis of ret/PTC gene rearrangements refines the fine needle aspiration diagnosis of thyroid cancer.
C C Cheung, B Carydis, S Ezzat, Y C Bedard, S L Asa. J Clin Endocrinol Metab 2001
137
20

Expression of PAX8-PPAR gamma 1 rearrangements in both follicular thyroid carcinomas and adenomas.
Ana Rita Marques, Carla Espadinha, Ana L Catarino, Sónia Moniz, Teresa Pereira, Luís G Sobrinho, Valeriano Leite. J Clin Endocrinol Metab 2002
244
20

Association of BRAF V600E mutation with poor clinicopathological outcomes in 500 consecutive cases of papillary thyroid carcinoma.
Cristiana Lupi, Riccardo Giannini, Clara Ugolini, Agnese Proietti, Piero Berti, Michele Minuto, Gabriele Materazzi, Rossella Elisei, Massimo Santoro, Paolo Miccoli,[...]. J Clin Endocrinol Metab 2007
307
20

ras mutations are associated with aggressive tumor phenotypes and poor prognosis in thyroid cancer.
Ginesa Garcia-Rostan, Hongyu Zhao, Robert L Camp, Marina Pollan, Agustin Herrero, Javier Pardo, Ran Wu, Maria Luisa Carcangiu, Jose Costa, Giovanni Tallini. J Clin Oncol 2003
263
19

Prevalence of Ras mutations in thyroid neoplasia.
C T Esapa, S J Johnson, P Kendall-Taylor, T W Lennard, P E Harris. Clin Endocrinol (Oxf) 1999
163
19

Molecular testing for mutations in improving the fine-needle aspiration diagnosis of thyroid nodules.
Yuri E Nikiforov, David L Steward, Toni M Robinson-Smith, Bryan R Haugen, Joshua P Klopper, Zhaowen Zhu, James A Fagin, Mercedes Falciglia, Katherine Weber, Marina N Nikiforova. J Clin Endocrinol Metab 2009
496
19

Development of thyroid papillary carcinomas secondary to tissue-specific expression of the RET/PTC1 oncogene in transgenic mice.
M Santoro, G Chiappetta, A Cerrato, D Salvatore, L Zhang, G Manzo, A Picone, G Portella, G Santelli, G Vecchio,[...]. Oncogene 1996
205
18

Targeted expression of the ret/PTC1 oncogene induces papillary thyroid carcinomas.
S M Jhiang, J E Sagartz, Q Tong, J Parker-Thornburg, C C Capen, J Y Cho, S Xing, C Ledent. Endocrinology 1996
233
18

RET/PTC oncogene activation is an early event in thyroid carcinogenesis.
G Viglietto, G Chiappetta, F J Martinez-Tello, F H Fukunaga, G Tallini, D Rigopoulou, R Visconti, A Mastro, M Santoro, A Fusco. Oncogene 1995
217
18


PAX8-PPARgamma rearrangement is frequently detected in the follicular variant of papillary thyroid carcinoma.
P Castro, A P Rebocho, R J Soares, J Magalhães, L Roque, V Trovisco, I Vieira de Castro, M Cardoso-de-Oliveira, E Fonseca, P Soares,[...]. J Clin Endocrinol Metab 2006
197
18

BRAF mutations and RET/PTC rearrangements are alternative events in the etiopathogenesis of PTC.
Paula Soares, Vítor Trovisco, Ana Sofia Rocha, Jorge Lima, Patrícia Castro, Ana Preto, Valdemar Máximo, Tiago Botelho, Raquel Seruca, Manuel Sobrinho-Simões. Oncogene 2003
501
17

Clinical implication of hot spot BRAF mutation, V599E, in papillary thyroid cancers.
Hiroyuki Namba, Masahiro Nakashima, Tomayoshi Hayashi, Naomi Hayashida, Shigeto Maeda, Tatiana I Rogounovitch, Akira Ohtsuru, Vladimir A Saenko, Takashi Kanematsu, Shunichi Yamashita. J Clin Endocrinol Metab 2003
434
17

High prevalence of RET/PTC rearrangements in Ukrainian and Belarussian post-Chernobyl thyroid papillary carcinomas: a strong correlation between RET/PTC3 and the solid-follicular variant.
G A Thomas, H Bunnell, H A Cook, E D Williams, A Nerovnya, E D Cherstvoy, N D Tronko, T I Bogdanova, G Chiappetta, G Viglietto,[...]. J Clin Endocrinol Metab 1999
179
17

PAX8-PPARgamma rearrangement in thyroid tumors: RT-PCR and immunohistochemical analyses.
Marina N Nikiforova, Paul W Biddinger, Christy M Caudill, Todd G Kroll, Yuri E Nikiforov. Am J Surg Pathol 2002
238
17

BRAF mutations in papillary thyroid carcinomas inhibit genes involved in iodine metabolism.
C Durante, E Puxeddu, E Ferretti, R Morisi, S Moretti, R Bruno, F Barbi, N Avenia, A Scipioni, A Verrienti,[...]. J Clin Endocrinol Metab 2007
272
17


Distinct multiple RET/PTC gene rearrangements in multifocal papillary thyroid neoplasia.
S L Sugg, S Ezzat, I B Rosen, J L Freeman, S L Asa. J Clin Endocrinol Metab 1998
225
16

Mutation of the PIK3CA gene in anaplastic thyroid cancer.
Ginesa García-Rostán, Angela M Costa, Isabel Pereira-Castro, Giuliana Salvatore, Radhames Hernandez, Mario J A Hermsem, Agustin Herrero, Alfredo Fusco, Jose Cameselle-Teijeiro, Massimo Santoro. Cancer Res 2005
245
16


Molecular classification of papillary thyroid carcinoma: distinct BRAF, RAS, and RET/PTC mutation-specific gene expression profiles discovered by DNA microarray analysis.
Thomas J Giordano, Rork Kuick, Dafydd G Thomas, David E Misek, Michelle Vinco, Donita Sanders, Zhaowen Zhu, Raffaele Ciampi, Michael Roh, Kerby Shedden,[...]. Oncogene 2005
280
15

A new oncogene in human thyroid papillary carcinomas and their lymph-nodal metastases.
A Fusco, M Grieco, M Santoro, M T Berlingieri, S Pilotti, M A Pierotti, G Della Porta, G Vecchio. Nature 1987
345
15

Mutational analysis of BRAF in fine needle aspiration biopsies of the thyroid: a potential application for the preoperative assessment of thyroid nodules.
Yoram Cohen, Eli Rosenbaum, Douglas P Clark, Martha A Zeiger, Christopher B Umbricht, Ralph P Tufano, David Sidransky, William H Westra. Clin Cancer Res 2004
179
15

Analysis of BRAF point mutation and RET/PTC rearrangement refines the fine-needle aspiration diagnosis of papillary thyroid carcinoma.
Giuliana Salvatore, Riccardo Giannini, Pinuccia Faviana, Alessia Caleo, Ilenia Migliaccio, James A Fagin, Yuri E Nikiforov, Giancarlo Troncone, Lucio Palombini, Fulvio Basolo,[...]. J Clin Endocrinol Metab 2004
205
15

Genetic alterations and their relationship in the phosphatidylinositol 3-kinase/Akt pathway in thyroid cancer.
Peng Hou, Dingxie Liu, Yuan Shan, Shuiying Hu, Kimberley Studeman, Stephen Condouris, Yangang Wang, Ariel Trink, Adel K El-Naggar, Giovanni Tallini,[...]. Clin Cancer Res 2007
287
15


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.